especially as income from Casgevy remains low in the near term, helping to diversify its commercial portfolio. Price Action: VRTX stock is down 0.46% at $411.47 at the last check on Tuesday.

Vertex (NASDAQ:VRTX) has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past (other than “dang, pain is a ...

The Sims 4 has confirmed a new kit in collaboration with popular content creator Lilsimsie. Releasing on January 16, the Comfy Gamer Kit features a range of gaming-themed Build/Buy items for Sims ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and Vertex Pharmaceuticals (VRTX). But which of these two stocks presents investors with the ...

Our first new content of 2025 looks likely to be a set of new Kits. There are several different types of DLC for The Sims 4, with the size and style of content varying greatly. Each has its own ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $402.49, demonstrating a -1.13% swing from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.55%.

Every year, around 220,000 people come to climb Mount Fuji, mostly packed into three hectic months between June and August when favourable weather conditions allow for scaling its summit.